Early Phase Trial Results Lead to FDA Fast Track Designation for Acute Myeloid Leukemia Treatment
Image credit: LASZLO | stock.adobe.com The FDA has granted Fast Track Designation to SELLAS Life Sciences Group, Inc’s…
Beyond the Ordinary Beyond the Obvious
Image credit: LASZLO | stock.adobe.com The FDA has granted Fast Track Designation to SELLAS Life Sciences Group, Inc’s…
Image credit: AIGen | stock.adobe.com The FDA has granted clearance to Neuralace Medical’s Axon Therapy, which is a…
Jen Lamppa, Associate Vice President, Clinical Analytics, Inovalon In the realm of clinical research, a highly selective process…
Image credit: blueringmedia | stock.adobe.com The FDA has granted Fast Track Designation (FTD) to RemeGen Co. Ltd’s mesothelin-targeting…
Image Credit: © FlowStudio – stock.adobe.com A commentary recently published on JAMA Network examined how often registered clinical…
Image Credit: © Aerial Mike – stock.adobe.com A recent study discovered a combination of 11 proteins that can…
Image credit: Yuliia | stock.adobe.com On November 23, 2023, the PDA Ireland Chapter hosted an event on Microbiology…
Image credit: Iryna | stock.adobe.com The FDA has accepted Shorla Oncology’s New Drug Application (NDA) for SH-105 to…
Image credit: Kristina Blokhin | stock.adobe.com The results of a Phase II trial show that AbbVie’s lutikizumab (ABT-981)…
Can you tell me about Indegene’s new study ‘Reshaping Pharmacovigilance in the Age of AI’? Sameer Lal: One…